New use of benzodiazepines and the risk of hip fracture: A case-crossover study;Neugebrauch von benzodiazepinen und das risiko einer proximalen femurfraktur: Eine case-crossover-studie

Zeitschrift fur Gerontologie und Geriatrie

Volumn 39, Issue 2, 2006, Pages 143-148

  Hoffmann, F ^a   Glaeske, G ^a  

^a UNIVERSITY OF BREMEN   (Germany)

Author keywords

Aged; Benzodiazepine; Case crossover; Hip fracture; Pharmacoepidemiology

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; ESTROGEN; NEUROLEPTIC AGENT; NOOTROPIC AGENT; THIAZIDE DIURETIC AGENT;

AGED; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HEALTH INSURANCE; HIP FRACTURE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PHARMACOEPIDEMIOLOGY; POPULATION RESEARCH; PRESCRIPTION; RISK ASSESSMENT; RISK FACTOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; BENZODIAZEPINES; CONFIDENCE INTERVALS; CROSS-OVER STUDIES; DATA COLLECTION; FEMALE; HIP FRACTURES; HUMANS; INSURANCE, HEALTH; MALE; ODDS RATIO; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 33645986949     PISSN: 09486704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00391-006-0337-y     Document Type: Article

References (23)

1. Barlett G, Abrahamowicz M, Tamblyn R, Grad R, Capek R, du Berger R (2004) Longitudinal patterns of new benzodiazepine use in the elderly. Pharmacoepidemiol Drug Saf 13(8):669-682
2. Cumming RG, Le Couteur DG (2003) Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 7(11):825-837
3. Fialova D, Topinkova E, Gambassi G et al. For the AdHOC Project Research Group (2005) Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 293(11):1348-1358
4. Garbe E, Suissa S (2004) Pharmacoepidemiology. In: Ahrens W, Pigeot I (Eds) Handbook of epidemiology. Springer, Berlin, pp 1225-1266
5. Herings RM, Stricker BH, de Boer A, Bakker A, Sturmans F (1995) Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med 155(16):1801-1807
6. Hoffmann F (2005) Benzodiazepine: Verordnungstrend erkennbar. In: Glaeske G, Janhsen K (Eds) GEK-Arzneimittel-Report 2005. Asgard, St. Augustin, pp 152-170
7. Kahn HA, Sempos CT (1989) Statistical methods in epidemiology. Oxford University Press, New York
8. Leipzig RM, Cumming RG, Tinetti ME (1999) Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 47(1):30-39
9. Maclure M (1991) The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 133(2):144-153
10. Maclure M, Mittleman MA (2000) Should we use a case-crossover design? Annu Rev Public Health 21:193-221
11. Madhusoodanan S, Bogunovic OJ (2004) Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf 3(5):485-493
12. Mort JR, Aparasu RR (2002) Prescribing of psychotropics in the elderly: why is it so often inappropriate? CNS Drugs 16(2):99-109
13. Neutel CI, Hirdes JP, Maxwell CJ, Patten SB (1996) New evidence on benzodiazepine use and falls: the time factor. Age Ageing 25(4):273-278
14. Pierfitte C, Macouillard G, Thicoipe M, Chaslerie A, Pehourcq F, Aissou M, Martinez B, Lagnaoui R, Fourrier A, Begaud B, Dangoumau J, Moore N (2001) Benzodiazepines and hip fractures in elderly people: case-control study. BMJ 322(7288):704-708
15. Ray WA, Griffin MR, Downey W (1989) Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 262(23):3303-3307
16. SAS Institute (2001) SAS. Statistical software, Version 8.2. Carry (NC), SAS Institute Inc
17. Schneeweiss S, Wang PS (2004) Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies. J Clin Psychopharmacol 24(6):632-638
18. Schneeweiss S, Wang PS (2005) Claims data studies of sedative-hypnotics and hip fractures in older people: exploring residual confounding using survey information. J Am Geriatr Soc 53(6):948-954
19. Sgadari A, Lapane KL, Mor V, Landi F, Bernabei R, Gambassi G (2000) Oxidative and nonoxidative benzodiazepines and the risk of femur fracture. J Clin Psychopharmacol 20(2):234-239
20. Stevens A, Mulrow C (1989) Drugs affecting postural stability and other risk factors in the hip fracture epidemic-case-control study. Community Med 11(1):27-34
21. Wagner AK, Zhang F, Soumerai SB, Walker AM, Gurwitz JH, Glynn RJ, Ross-Degnan D (2004) Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med 164(14):1567-1572
22. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J (2001) Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 158(6):892-898
23. Wolter-Henseler DK (1999) Benzodiazepine: Verordnung, Einnahme, Missbrauch und Abhängigkeit im Alter. Z Gerontopsych Gerontopsychiatr 12(2):115-128